This review highlights preclinical evaluation challenges of porcine corneal models for innovative therapies, suggesting new directions.
The development of advanced biomaterials for corneal applications requires robust translational platforms that faithfully replicate human characteristics. Porcine corneas are increasingly recognized for ophthalmic research. Their unique combination of anatomical similarity, biomechanical comparability, and accessibility make them highly suitable for preclinical evaluation of innovative therapies, bridging the gap between preclinical discovery and clinical application. This review outlines the utility of porcine corneal models in validating advanced biomaterials, particularly in ex vivo settings, focusing on current methodologies, while addressing challenges and future directions. We aim to underscore the potential of porcine corneal models to accelerate the translation of next-generation biomaterials into clinically relevant corneal therapies.
No takes yet. Share an insight, caveat, or question.
Nápoles et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: